Suppr超能文献

世界卫生组织欧洲区域成员国中注射吸毒者对乙型和丙型病毒性肝炎的政策应对:世卫组织2013年全球肝炎政策调查的子分析

Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey.

作者信息

Spina Alexander, Eramova Irina, Lazarus Jeffrey V

出版信息

BMC Infect Dis. 2014;14 Suppl 6(Suppl 6):S15. doi: 10.1186/1471-2334-14-S6-S15. Epub 2014 Sep 19.

Abstract

BACKGROUND

Unsafe injections, through infectious bodily fluids, are a major route of transmission for hepatitis B and C. Viral hepatitis burden among people who inject drugs is particularly high in many Member States of central and Eastern Europe while national capacity and willingness to address it varies greatly.

METHODS

The initial survey included 43 questions covering awareness, data, prevention, and screening and treatment. It was sent in five languages to identified national focal points. This sub-analysis included 11 questions and 53 Member States in the WHO European Region. Descriptive analyses of national activities are presented. As a secondary outcome bivariate analyses of differences between Member States of the European Union (EU) and European Free Trade Association (EFTA) compared to those not in said grouping are presented.

RESULTS

Forty-four of the 53 Member States responded to the survey (response rate of 83%). More than three-quarters reported offering publicly-funded treatment for HBV or HCV (82% and 80%, respectively), with a significantly higher proportion of EU/EFTA Member States (P=0.004 and P=0.010, respectively). Half of Member States (53%) reported the existence of a national policy for hepatitis prevention and control; however less than one-third (27%) reported having written national strategies. Under half of the responding Member States reported holding events for World Hepatitis Day 2012. One-fifth reported offering hepatitis B and C testing free of charge, with less than one-third reportedly conducting regular serosurveys among people who inject drugs.

CONCLUSIONS

Findings highlight key gaps requiring attention in order to improve national policies and programmes in the region and ensure an adequate response to injection drug use-associated viral hepatitis. Further studies are required to assess quality and impact of national policies and services.

摘要

背景

不安全注射通过传染性体液传播,是乙型和丙型肝炎的主要传播途径。在中东欧的许多成员国中,注射吸毒者的病毒性肝炎负担尤为严重,而各国应对这一问题的能力和意愿差异很大。

方法

初始调查包括43个问题,涵盖认知、数据、预防以及筛查和治疗。调查以五种语言发送给确定的国家联络点。本次子分析包括世界卫生组织欧洲区域的11个问题和53个成员国。呈现了各国活动的描述性分析。作为次要结果,还呈现了对欧盟(EU)和欧洲自由贸易联盟(EFTA)成员国与未加入上述集团的成员国之间差异的双变量分析。

结果

53个成员国中有44个回复了调查(回复率为83%)。超过四分之三的国家报告提供针对乙肝或丙肝的公共资助治疗(分别为82%和80%),欧盟/欧洲自由贸易联盟成员国的比例显著更高(分别为P = 0.004和P = 0.010)。一半的成员国(53%)报告存在国家肝炎预防和控制政策;然而,不到三分之一(27%)的国家报告有书面的国家战略。不到一半的回复成员国报告举办了2012年世界肝炎日活动。五分之一的国家报告提供免费的乙肝和丙肝检测,据报道,不到三分之一的国家对注射吸毒者进行定期血清学调查。

结论

研究结果突出了一些关键差距,需要予以关注,以改进该地区的国家政策和计划,并确保对与注射吸毒相关的病毒性肝炎作出充分应对。需要进一步研究以评估国家政策和服务的质量及影响。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验